Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03585400 · ClinicalTrials.gov registry record

Validation of the REPS Prediction Tool

A clinical trial of Postoperative Respiratory Complication and Residual Neuromuscular Blockade, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
101,510
Enrollment target
1
Study location

NCT03585400 is a study of Postoperative Respiratory Complication and Residual Neuromuscular Blockade that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 101,510 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03585400, a study of Postoperative Respiratory Complication and Residual Neuromuscular Blockade, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
101,510 participants
Enrollment target
1
Study location

Study Summary

Neuromuscular blocking agents' (NMBA) use during surgery is associated with postoperative respiratory complications and increased risk of readmission to the hospital following ambulatory surgery. Residual neuromuscular block (rNMB) after surgery is difficult to identify. We have recently developed the REsidual neuromuscular block Prediction Score (REPS), that predicts the risk for postoperative rNMB. Our primary objective is now to assess the predictive ability of the REPS for respiratory complications within seven days following general anaesthesia. The secondary objective is to compare the predictive values of REPS and train-of-four (TOF)-ratio below 0.90 for respiratory complications.

Interventions

  • OTHER Observational Study

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 101,510 participants
Start Date 2018-06-29
Est. Completion 2020-12-31

What the Registry Record Tells You About NCT03585400

The ClinicalTrials.gov registry entry for NCT03585400 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101,510 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Postoperative Respiratory Complication appearing as the primary indexed condition, and to 1 intervention - of which Observational Study is the first listed.

NCT03585400 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03585400 about?

NCT03585400 is a clinical study titled "Validation of the REPS Prediction Tool". Neuromuscular blocking agents' (NMBA) use during surgery is associated with postoperative respiratory complications and increased risk of readmission to the hospital following ambulatory surgery. Residual neuromuscular block (rNMB) after surgery is difficult to identify. We have recently developed t...

What is the current status of trial NCT03585400?

This trial is currently completed. The enrollment target is 101,510 participants. The study started on 2018-06-29. Estimated completion is 2020-12-31.

What conditions does trial NCT03585400 study?

This clinical trial studies the following conditions: Postoperative Respiratory Complication, Residual Neuromuscular Blockade, Curarization, Postoperative Residual.

What interventions are being tested in trial NCT03585400?

The interventions under investigation include: Observational Study (OTHER).

Who is sponsoring clinical trial NCT03585400?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03585400 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Respiratory Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.